surmount-1 tirzepatide trial obesity without diabetes for maintenance of bodyweight reduction in people with in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled Tirzepatide for Obesity: Highlights from

Storage: -20C (long-term), 2-8C (short-term)

This works with the slowed gastric emptying rather than against it

You can read the full article at Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial Little is known about the effects of tirzepatide, a medication that stimulates both the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, when added to insulin glargine for treating type 2 diabetes

Upper Arms Can be used if another person is administering the injection

This approval makes it available to a wider population

Among these adipokines, adiponectin stands out as one with multiple beneficial effects on insulin sensitivity and cardiovascular well-being